Greece vs Japan: Cause of death, by non-communicable diseases, ages 15-59, female
Greece
80.2%
in 2021
Japan
79.1%
in 2021
Greece rank
25th
Japan rank
28th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Greece
- Japan
How they compare
Greece currently reports 80.2% against 79.1% in Japan, a difference of 1.1%.
Across all 6 years both countries report, Greece has been ahead every year.
Greece ranks 25th and Japan ranks 28th of 185 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.7% | 78.2% | 5.5% | Greece |
| 2010s | 88.4% | 79.3% | 9.1% | Greece |
| 2020s | 83.6% | 79.5% | 4.1% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Greece or Japan?
- Greece, at 80.2% against 79.1% in Japan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Greece and Japan?
- 1.1%, with Greece ahead.
- How many years of comparable data are there for Greece and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do Greece and Japan rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Greece ranks 25th and Japan ranks 28th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.